Enzymatic resolution of (±)-trans-4-(4′-fluorophenyl)-6-oxo-piperidin-3-ethyl carboxylate, an intermediate in the synthesis of (−)-Paroxetine

Add time:08/23/2019    Source:sciencedirect.com

The enantioselective hydrolysis of (±)-trans-4-(4′-fluorophenyl)-6-oxo-piperidin-3-ethyl carboxylate using four different microbial lipases was examined. This ester was found to be a poor substrate for most lipases, the activity achieved with the lipase from Candida antarctica (fraction B) (CAL-B) being the highest. This enzyme was purified via adsorption on hydrophobic supports and immobilized using different protocols. The enzyme immobilized on octadecyl-Sepabeads was not enantioselective at all (E=1). In contrast, glyoxyl-CAL-B preparation gave the unreacted (3S,4R)-ester in enantiomerically pure form (enantiomeric excess >99%) at 50% conversion. No decrease in the enzyme activity, or alteration in the enantioselectivity were detected, even after ten reaction cycles.

We also recommend Trading Suppliers and Manufacturers of (E)-2-Fluoro-3-(4-fluorophenyl)-propenoic acid, ethyl ester (cas 111055-87-9). Pls Click Website Link as below: cas 111055-87-9 suppliers

Prev:Establishment of a quantitative bioanalytical method for an acetylcholinesterase inhibitor Ethyl 3-(2-(4-fluorophenyl) amino)-4-phenylthiazol-5-yl)-3-oxopropanoate including its physicochemical characterization and in vitro metabolite profiling using Liquid Chromatography-Mass Spectrometry
Next:A concise synthesis of (S)-(+)-1-(4-{2-[bis-(4-fluorophenyl)methoxy]-ethyl}piperazin-1-yl)-2-phenylpropan-2-ol dimaleate)